monoisoamyl-2,3-dimercaptosuccinate has been researched along with oxalic acid in 1 studies
| Studies (monoisoamyl-2,3-dimercaptosuccinate) | Trials (monoisoamyl-2,3-dimercaptosuccinate) | Recent Studies (post-2010) (monoisoamyl-2,3-dimercaptosuccinate) | Studies (oxalic acid) | Trials (oxalic acid) | Recent Studies (post-2010) (oxalic acid) |
|---|---|---|---|---|---|
| 53 | 0 | 19 | 2,083 | 54 | 748 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flora, SJ; Jaiswal, DK; Kannan, GM; Pant, BP | 1 |
1 other study(ies) available for monoisoamyl-2,3-dimercaptosuccinate and oxalic acid
| Article | Year |
|---|---|
Combined administration of oxalic acid, succimer and its analogue for the reversal of gallium arsenide-induced oxidative stress in rats.
Topics: Aminolevulinic Acid; Animals; Arsenicals; Chelating Agents; Copper; Drug Therapy, Combination; Gallium; Glutathione; Glutathione Disulfide; Kidney; Liver; Male; Malondialdehyde; Oxalic Acid; Oxidative Stress; Porphobilinogen Synthase; Protoporphyrins; Rats; Rats, Wistar; Spleen; Succimer; Tissue Distribution; Zinc | 2002 |